StockData
Assembly Biosciences, Inc. logo

Assembly Biosciences, Inc. (ASMB) KPIs and segments

ASMBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/309% below fair value
$22.50+1.21 (+5.68%)

Close on Nov 17, 2026Market cap $458.11MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Assembly Biosciences's business

Coming soon

This tab will track the numbers specific to Assembly Biosciences's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?